SecBot SecBot
144 ·Filed Oct 30, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed17d 6h ago SEC0001950047-26-010508
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine 10b5-1 plan sale by the CFO; the dollar amount is immaterial relative to the $61.2B market cap. Monitor for any acceleration of insider selling or changes in the 10b5-1 plan, but no immediate catalyst is indicated.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$378.92
T+0 close · Oct 30, 2026 · via day close
Latest settled
−15.45%
T+5 · $320.39 · next T+20 in 14d
Vs SPY
−15.53%
α at T+5
Latest observation
−16.32%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $378.92entry
  2. T+1 · 14d ago +2.56%α +2.26% · $388.63
  3. T+5 · 8d ago −15.45%α −15.53% · $320.39
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Natera CFO Michael Brophy filed a Form 144 notice of intent to sell 1,906 shares of common stock, with an approximate market value of $831,016 based on the filing date. The shares were acquired via restricted stock unit vesting on October 27, 2026, and the sale is planned under a Rule 10b5-1 trading plan. The filing also reports three recent sales by Brophy on October 27-28, 2026 totaling 3,157 shares for about $1.33 million, and two earlier sales in July-August 2026 for about $216,000.

Key Facts

  • CFO Michael Brophy filed Form 144 to sell 1,906 shares of Natera common stock.
  • Shares were acquired via restricted stock unit vesting on October 27, 2026.
  • The proposed sale is under a Rule 10b5-1 trading plan.
  • Brophy also sold 3,157 shares on October 27-28, 2026 for ~$1.33 million.
  • Two earlier sales in July-August 2026 totaled 795 shares for ~$216,000.
  • Natera market cap is $61.2B; the proposed sale represents ~0.0014% of shares outstanding.
  • Recent insider activity (30 days) shows 10 sells totaling $4.5M.

Financial Impact

Proposed sale of 1,906 shares valued at ~$831,016; recent total insider sales (including this plan) of ~$2.4M over 30 days.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Insider selling is routine for executives with RSU vesting; not a signal of deteriorating fundamentals.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
90% bullish (30 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010508
Document: 0001950047-26-010508-index.html0001950047-26-010508
Document: 0001950047-26-010508.txt0001950047-26-010508

Track record

63 reports on NTRA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
  2. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
  3. Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
  5. Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
  6. Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
  7. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
  8. Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
Showing 10 of 63

US Market Status

Market Closed · Opens Wed (11h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026